Crestline Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$1.31M Buy
2022
Q3
Sell
2022
Q2
$1.96M Buy
2022
Q1
$1.24M Buy
2021
Q4
$1.37M Buy
2021
Q3
Sell
2021
Q2
$988K Buy
2017
Q4
Sell
2017
Q3
$3.49M Buy
2017
Q2
$2.59M Buy
2017
Q1
Sell
2016
Q4
$1.65M Buy
2016
Q3
$1.12M Buy